Back to Search Start Over

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay

Authors :
Lana M. Chahine
Thomas G. Beach
Charles H. Adler
Monica Hepker
Anumantha Kanthasamy
Scott Appel
Sandra Pritzkow
Michelle Pinho
Sherri Mosovsky
Geidy E. Serrano
Christopher Coffey
Michael C. Brumm
Luis M. A. Oliveira
Jamie Eberling
Brit Mollenhauer
For the Systemic Synuclein Sampling Study
Source :
Annals of Clinical and Translational Neurology, Vol 10, Iss 5, Pp 696-705 (2023)
Publication Year :
2023
Publisher :
Wiley, 2023.

Abstract

Abstract Objectives Detection of α‐synuclein aggregates by seed amplification is a promising Parkinson disease biomarker assay. Understanding intraindividual relationships of α‐synuclein measures could inform optimal biomarker development. The objectives were to test accuracy of α‐synuclein seed amplification assay in central (cerebrospinal fluid) and peripheral (submandibular gland) sources, compare to total α‐synuclein measures, and investigate within‐subject relationships. Methods The Systemic Synuclein Sampling Study aimed to characterize α‐synuclein in multiple tissues and biofluids within Parkinson disease subjects (n = 59) and compared to healthy controls (n = 21). Motor and non‐motor measures and dopamine transporter scans were obtained. Four measures of α‐synuclein were compared: seed amplification assay in cerebrospinal fluid and formalin‐fixed paraffin‐embedded submandibular gland, total α‐synuclein quantified in biofluids using enzyme‐linked immunoassay, and aggregated α‐synuclein in submandibular gland detected by immunohistochemistry. Accuracy of seed amplification assay for Parkinson disease diagnosis was examined and within‐subject α‐synuclein measures were compared. Results Sensitivity and specificity of α‐synuclein seed amplification assay for Parkinson disease diagnosis was 92.6% and 90.5% in cerebrospinal fluid, and 73.2% and 78.6% in submandibular gland, respectively. 25/38 (65.8%) Parkinson disease participants were positive for both cerebrospinal fluid and submandibular gland seed amplification assay. Comparing accuracy for Parkinson disease diagnosis of different α‐synuclein measures, cerebrospinal fluid seed amplification assay was the highest (Youden Index = 83.1%). 98.3% of all Parkinson disease cases had ≥1 measure of α‐synuclein positive. Interpretation α‐synuclein seed amplification assay (cerebrospinal fluid>submandibular gland) had higher sensitivity and specificity compared to total α‐synuclein measures, and within‐subject relationships of central and peripheral α‐synuclein measures emerged.

Details

Language :
English
ISSN :
23289503
Volume :
10
Issue :
5
Database :
Directory of Open Access Journals
Journal :
Annals of Clinical and Translational Neurology
Publication Type :
Academic Journal
Accession number :
edsdoj.55394691e8324b6891e055c38a0be7d4
Document Type :
article
Full Text :
https://doi.org/10.1002/acn3.51753